US Patent Issued to Mary Hitchcock Memorial Hospital, for itself and on behalf of Dartmouth-Hitchcock Clinic on Nov. 25 for "System and method for monitoring molecular agents in vivo by estimating magnetic nanoparticle aggregation" (New Hampshire Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,934, issued on Nov. 25, was assigned to Mary Hitchcock Memorial Hospital, for itself and on behalf of Dartmouth-Hitchcock Clinic (Lebanon, N.H.).

"System and method for monitoring molecular agents in vivo by estimating magnetic nanoparticle aggregation" was invented by John B. Weaver (Hanover, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a system and method for use of MSB with respect to nanoparticles to non-invasively so as to detect certain conditions, such as viral infection and immunological responses thereto. The system and method employs MSB, for example to detect and quantify antibody-specific NP aggregation to ...